$188.10 – $3,779.00
Hepcinat LP Tablets contain two antiviral medications, Ledipasvir and Sofosbuvir. They work by lowering the amount of hepatitis C virus in the body and gradually removing the infection from the bloodstream.
Active Ingredients: Sofosbuvir 400mg & Ledipasvir 90mg
Hepcinat LP Tablets are the combination of two antiviral medicines Sofosbuvir, Ledipasvir. It is a prescription medicine used to treat chronic hepatitis C virus (HCV) infection. Hepcinat-LP fights against the viruses to resolve the infection.
Hepcinat-LP Tablet should always be taken in the indicated dose and time frame. Hepcinat-LP Tablet can be taken with or without food, but it should be taken at the same time every day. It is not advisable to consume more than what your doctor has prescribed. If you have any medical issues, such as liver or kidney illness, you must notify your doctor. It is dangerous to consume alcohol while taking this medication, thus it is best to minimize or avoid alcohol. To achieve the best outcomes, the course of medicine should be finished.
Tiredness and headache are common adverse effects of this medication. To avoid or overcome the adverse effects, drink plenty of fluids and eat a balanced diet.
Hepcinat-LP Tablet must always be taken, exactly as directed. Before taking the drug, tell your doctor if you are taking any other prescriptions or supplements.
buyprepmeds.com is one of the most reputed online pharmacies delivering worldwide. It is the ideal place to buy Hepcinat-LP tablets online in the USA or any other country as the prices are extremely competitive, and the orders are sent in discreet-looking packages without any mention of the contents on the package. Hepcinat-LP tablets price displayed above is before discount. You are eligible for an extra discount when you pay by crypto. We provide full confidentiality and anonymity to our customers. Buy prep online at amazing prices from buyprepmeds.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.